\n\n\n\n\t\t\n\t\t\tArbor Surgical Technologies\n\t\t\thttp://www.arborsurgical.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tArbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement...More»
\n\t\t\tArbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superi«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tPortola Valley, CA, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\theart,\n\t\t\t\theart valve,\n\t\t\t\tcadiovascular,\n\t\t\t\tartery,\n\t\t\t\tcardiac,\n\t\t\t\tarbor surgical technologies,\n\t\t\t\tarbor tech\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series B - $20M (09/20/2005)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tAffinity Capital Management,\n\t\t\t\t\t\n\t\tAlloy Ventures,\n\t\t\t\t\t\n\t\tBaird Venture Partners,\n\t\t\t\t\t\n\t\tDelphi Ventures,\n\t\t\t\t\t\n\t\tSage Venture Partners,\n\t\t\t\t\t\n\t\tSapient,\n\t\t\t\t\t\n\t\tThree Arch Partners,\n\t\t\t\t\t\n\t\tJohnson & Johnson Development Corporation,\n\t\t\t\t\t\n\t\tKaiser Venture Capital\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tEvalve\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tHeartsine Technologies,\n\t\t\t\t\tCorepair,\n\t\t\t\t\tAcumen Medical,\n\t\t\t\t\tNewCardio,\n\t\t\t\t\tEvalve,\n\t\t\t\t\tFlowCardia,\n\t\t\t\t\tCoreValve,\n\t\t\t\t\tEBR Systems\n\t\t\t\t
\n\t\t\t